Maria João Saraiva

Has grant

University of Porto
Country flagPortugal

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Molecular mechanisms in the clearance of protein aggregates in misfolding disorders

Open Date: 2013-07-01

Close Date: 2015-06-30

Grant: Close

Molecular mechanisms in the clearance of protein aggregates in misfolding disorders

Open Date: 2013-07-01

Close Date: 2015-06-01

Grant: Close

Molecular basis of nervous system dysfunction on amyloid neuropathies

Open Date: 2011-01-01

Close Date: 2013-06-30

Grant: Close

Therapies in familial amyloidotic polyneuropathy

Open Date: 2009-01-01

Close Date: 2011-03-01

Grant: Close

Therapies in familial amyloidotic polyneuropathy

Open Date: 2009-01-01

Close Date: 2011-03-31

Articles (16)

Hereditary amyloid transthyretin (ATTRv) amyloidosis is a fatal neurodegenerative disorder, first identified in Portugal. The most common transthyretin (TTR) mutation in ATTRv results from an exchange of a methionine for a valine at position 30 (V30M). ATTRv is characterized by the extracellular deposition of aggregates and fibrils of mutant forms of TTR, particularly in the nerves and ganglia of the peripheral nervous system (PNS). This phenotype is often accompanied by the lack of inflammatory infiltrates, despite the importance of macrophages in removal of TTR deposits in ATTRv patients. The mechanisms underlying this impairment of inflammatory responses in ATTRv patients are poorly understood. Here, we show a significant down-regulation in the expression of several chemokines by bone marrow-derived macrophages (BMDM) generated from V30M TTR mice upon stimulation with toll-like receptor 4 (TLR4) and TLR2 agonists. The phosphorylation of the MAP kinase p38, important for TLR4 and TLR2 signaling pathways, was also down-regulated in V30M macrophages, as compared with wild-type (WT) ones. The present study contributes with new insights to unravel the molecular mechanisms underlying the lack of inflammatory immune responses observed in ATTRv patients and may help in the development of new immune therapeutic strategies for the disease.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Sonia Batista

-

PORTUGAL
View details

Carlos B. Duarte

Full Professor

University of Coimbra

PORTUGAL
View details

Isabel Conceição

Universidade de Aveiro

PORTUGAL
View details

Maria Almeida

Associate Professor

University of Porto

PORTUGAL
View details

Ole Suhr

Senior Professor

Umeå Universitet Medicinska fakulteten

SWEDEN
View details

Ana Terceiro

Instituto Universitário de Ciências da Saúde

PORTUGAL
View details

Rui Magalhães

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar

PORTUGAL
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.